• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ABBOTT VASCULAR RX XIENCE XPEDITION 48; DRUG ELUTING CORONARY STENT DELIVERY SYSTEM

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ABBOTT VASCULAR RX XIENCE XPEDITION 48; DRUG ELUTING CORONARY STENT DELIVERY SYSTEM Back to Search Results
Catalog Number 1078250-48
Device Problems Difficult to Advance (2920); Activation Failure (3270)
Patient Problem No Consequences Or Impact To Patient (2199)
Event Date 04/04/2020
Event Type  malfunction  
Manufacturer Narrative
The device is expected to be returned for evaluation.It has not yet been received.A follow up report will be submitted with all additional relevant information.
 
Event Description
It was reported that the procedure was to treat a mildly tortuous and moderately calcified lesion in the mid left anterior descending (lad) artery.The 2.50x48mm rx xience xpedition stent delivery system (sds) was advanced to the lesion with resistance noted.When pressurized to 14 atmospheres (atm), the balloon would not inflate.Pressure was increased to 16 atm however the balloon still would not inflate.The sds was removed and replaced with a new xpedition to complete the procedure.There was no clinically significant delay in the procedure and no adverse patient effects.No additional information was provided.
 
Manufacturer Narrative
The device was returned for analysis.The reported activation failure including expansion failures/failure to deploy was able to be confirmed.The reported difficult to advance was unable to be replicated in a testing environment as it was based on operational circumstances.A tear in the outer member was observed proximal to the proximal seal.A review of the lot history record identified no manufacturing nonconformities issued to the reported lot that would have contributed to this event.Additionally, a review of the complaint history identified no other similar incidents from this lot.The investigation determined the reported difficulties appear to be related to circumstances of the procedure as it is likely that during advancement resistance was met with lesion resulting in the reported difficult to advance.Interaction and/or manipulation of the device resulted in the noted tear in the outer member, thus resulting in the reported activation failure/failure to deploy.There is no indication of a product quality issue with respect to manufacture, design or labeling.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
RX XIENCE XPEDITION 48
Type of Device
DRUG ELUTING CORONARY STENT DELIVERY SYSTEM
Manufacturer (Section D)
ABBOTT VASCULAR
26531 ynez rd.
temecula CA 92591 4628
MDR Report Key9969055
MDR Text Key188097900
Report Number2024168-2020-03708
Device Sequence Number1
Product Code NIQ
Combination Product (y/n)Y
PMA/PMN Number
P110019
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,distri
Type of Report Initial,Followup
Report Date 06/17/2020
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received04/16/2020
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date02/11/2023
Device Catalogue Number1078250-48
Device Lot Number0020441
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer05/14/2020
Date Manufacturer Received06/10/2020
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
-
-